Étude de cas

Experiences with the MCV 5-dose Switch from Africa's EPI

This video series features interviews with EPI Managers, as well as UNICEF and WHO regional leads, sharing firsthand experiences from countries transitioning from 10-dose to 5-dose vials for the measles/MR vaccine. Experts discuss key questions such as: Why are African countries making the switch to 5-dose vials for routine immunization programs? What does the transition process look like? How does it impact vaccine coverage, wastage, costs, and overall program effectiveness?

These interviews were recorded by the United Nations Children's Fund Regional Office for Eastern and Southern Africa (UNICEF ESARO) during the 2023 EPI Managers' Meeting in Addis Ababa, Ethiopia, with additional follow-up discussions conducted at the UNICEF Regional Office in Kenya.

Langues

  • Anglais

Année de publication

2023

Type

Étude de cas

Catégories

  • Vaccins et dispositifs d'administration

Maladies

  • Rougeole

Pays

  • Afrique

Régions de l'OMS

  • Région africaine

Références sur le sujet

MCV5-COUNTRIES

TitreAuteurAnnéeTypeLangue
Experiences with the MCV 5-dose Switch from Africa's EPIUNICEF Regional Office for Eastern and Southern Africa (ESARO)2023Case studyAnglais
MCV 5-dose Asia Pacific Map and OverviewLinksbridge2022Poster/infographicAnglais
MCV 5-dose Switches in the WHO Africa RegionLinksbridge2024Poster/infographicAnglais
The Transition from MCV 10-dose to 5-dose in IndiaLinksbridge2022Case studyAnglais

Ajouté par: Sassenach

Ajouté le: 2025-02-14 19:01:47

Consultations: 346